<a href="https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing">Subscribe to UnitedHealthcare's Community & State newsletter</a>.In this episode, Rob Lott interviews Jennifer Kao of the UCLA Anderson School of Management in front of a live audience about her paper in the October 2025 issue of Health Affairs exploring <a href="https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2024.01476?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=october+2025+issue">the impact of risk evaluation and mitigation strategies</a> on generic approvals of US pharmaceutical products.<a href="https://www.pubservice.com/backissue/subbi.aspx?CO=PJ&PC=HR&BI=HRI&utm_medium=podcast&utm_source=A+health+podyssey">Order the October 2025 issue of Health Affairs</a>.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. <a href="https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider">With your support</a>, we can continue to keep our digital publication Forefront and podcast
<a href="https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing">Subscribe to UnitedHealthcare's Community & State newsletter</a>.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

A Health Podyssey

AI Chapters

AI Insights

Reviews